Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol's Opdivo boosts kidney cancer survival beyond two years
Bristol's Opdivo boosts kidney cancer survival beyond two years
Bristol's Opdivo boosts kidney cancer survival beyond two years
Submitted by
admin
on September 26, 2015 - 9:54am
Source:
Yahoo/Reuters
News Tags:
Bristol-Myers Squibb
Opdivo
kidney cancer
Novartis
Afinitor
Headline:
Bristol's Opdivo boosts kidney cancer survival beyond two years
Do Not Allow Advertisers to Use My Personal information
